Apellis Pharmaceuticals, Inc. (APLS)
USD 18.53
(-7.21%)
USD 18.53
(-7.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -517.12 Million USD | 13.03% |
| 2022 | -594.61 Million USD | -10.88% |
| 2021 | -536.27 Million USD | -150.92% |
| 2020 | -213.72 Million USD | 25.79% |
| 2019 | -288.01 Million USD | -125.14% |
| 2018 | -127.92 Million USD | -151.98% |
| 2017 | -50.76 Million USD | -86.08% |
| 2016 | -27.28 Million USD | 41.42% |
| 2015 | -46.57 Million USD | -312.36% |
| 2014 | -11.29 Million USD | -180.28% |
| 2013 | -4.02 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -62.09 Million USD | 26.54% |
| 2024 Q2 | -29.44 Million USD | 52.58% |
| 2024 Q3 | -67.53 Million USD | -60.58% |
| 2023 Q4 | -84.51 Million USD | 43.01% |
| 2023 FY | -517.12 Million USD | 13.03% |
| 2023 Q2 | -120.44 Million USD | 31.21% |
| 2023 Q3 | -148.29 Million USD | -23.13% |
| 2023 Q1 | -175.08 Million USD | -6.72% |
| 2022 Q3 | -152.93 Million USD | -2.9% |
| 2022 FY | -594.61 Million USD | -10.88% |
| 2022 Q2 | -148.62 Million USD | -15.21% |
| 2022 Q1 | -128.99 Million USD | -44.29% |
| 2022 Q4 | -164.05 Million USD | -7.27% |
| 2021 Q4 | -89.4 Million USD | 30.15% |
| 2021 Q1 | -124.59 Million USD | -195.75% |
| 2021 Q2 | -194.28 Million USD | -55.94% |
| 2021 Q3 | -127.99 Million USD | 34.12% |
| 2021 FY | -536.27 Million USD | -150.92% |
| 2020 FY | -213.72 Million USD | 25.79% |
| 2020 Q3 | -129.55 Million USD | -12.16% |
| 2020 Q2 | -115.5 Million USD | -16.93% |
| 2020 Q1 | -98.78 Million USD | 6.75% |
| 2020 Q4 | 130.12 Million USD | 200.44% |
| 2019 Q3 | -69.94 Million USD | -10.2% |
| 2019 Q2 | -63.47 Million USD | -30.47% |
| 2019 FY | -288.01 Million USD | -125.14% |
| 2019 Q1 | -48.65 Million USD | -30.79% |
| 2019 Q4 | -105.94 Million USD | -51.46% |
| 2018 FY | -127.92 Million USD | -151.98% |
| 2018 Q4 | -37.19 Million USD | -3.89% |
| 2018 Q3 | -35.8 Million USD | -6.93% |
| 2018 Q2 | -33.48 Million USD | -56.2% |
| 2018 Q1 | -21.43 Million USD | -19.15% |
| 2017 Q2 | -12.13 Million USD | -34.02% |
| 2017 FY | -50.76 Million USD | -86.08% |
| 2017 Q4 | -17.99 Million USD | -55.25% |
| 2017 Q3 | -11.58 Million USD | 4.48% |
| 2017 Q1 | -9.05 Million USD | -35.54% |
| 2016 Q3 | -7.23 Million USD | -8.22% |
| 2016 Q4 | -6.67 Million USD | 7.68% |
| 2016 FY | -27.28 Million USD | 41.42% |
| 2016 Q2 | -6.68 Million USD | 0.0% |
| 2016 Q1 | -6.68 Million USD | 4.02% |
| 2015 Q2 | -3.98 Million USD | 0.0% |
| 2015 Q4 | -6.96 Million USD | 77.99% |
| 2015 Q3 | -31.64 Million USD | -694.97% |
| 2015 Q1 | -3.98 Million USD | -36.49% |
| 2015 FY | -46.57 Million USD | -312.36% |
| 2014 Q3 | -2.66 Million USD | 6.52% |
| 2014 Q2 | -2.85 Million USD | 0.0% |
| 2014 Q4 | -2.91 Million USD | -9.3% |
| 2014 FY | -11.29 Million USD | -180.28% |
| 2014 Q1 | -2.85 Million USD | 0.0% |
| 2013 FY | -4.02 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -118.004% |
| Alkermes plc | 414.12 Million USD | 224.872% |
| Agenus Inc. | -159.54 Million USD | -224.114% |
| Aptorum Group Limited | -10.52 Million USD | -4814.043% |
| Ardelyx, Inc. | -63.27 Million USD | -717.247% |
| Dyadic International, Inc. | -8.22 Million USD | -6183.565% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -43282.634% |
| Lantern Pharma Inc. | -17.87 Million USD | -2792.569% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -2474.049% |
| Novavax, Inc. | -566.51 Million USD | 8.718% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -608.589% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -529.132% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -2563.03% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -4795.588% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -873.379% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -35.907% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2027.491% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1265.552% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -300.906% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -516.251% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2848.406% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -1075.008% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1981.472% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -271.947% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -83.263% |
| AlloVir, Inc. | -181.33 Million USD | -185.181% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -152.252% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1667.452% |
| Bicycle Therapeutics plc | -189.94 Million USD | -172.246% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -201.033% |
| ChromaDex Corporation | -5.59 Million USD | -9135.953% |
| Chimerix, Inc. | -93.06 Million USD | -455.656% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -1047.187% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -345.567% |
| CRISPR Therapeutics AG | -222.53 Million USD | -132.374% |
| Precision BioSciences, Inc. | -43.73 Million USD | -1082.369% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -171.439% |
| Fortress Biotech, Inc. | -142.34 Million USD | -263.295% |
| Fortress Biotech, Inc. | -142.34 Million USD | -263.295% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -429.327% |
| ImmuCell Corporation | -5.74 Million USD | -8896.416% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -284.68% |
| Immix Biopharma, Inc. | -16.14 Million USD | -3103.751% |
| Incyte Corporation | 620.52 Million USD | 183.336% |
| Innoviva, Inc. | 176.7 Million USD | 392.64% |
| IO Biotech, Inc. | -91.44 Million USD | -465.512% |
| Jaguar Health, Inc. | -34.29 Million USD | -1408.037% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -204.294% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 4430.271% |
| ContextLogic Inc. | -328 Million USD | -57.659% |
| MiMedx Group, Inc. | 37.11 Million USD | 1493.256% |
| MEI Pharma, Inc. | 14.54 Million USD | 3656.051% |
| NextCure, Inc. | -67.63 Million USD | -664.553% |
| Onconetix, Inc. | -36.03 Million USD | -1335.068% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -1139.682% |
| Opthea Limited | -191.84 Million USD | -169.555% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -18691.929% |
| Vaxcyte, Inc. | -468.04 Million USD | -10.486% |
| PDS Biotechnology Corporation | -43.04 Million USD | -1101.343% |
| Precigen, Inc. | -88.92 Million USD | -481.538% |
| Pharming Group N.V. | -4.87 Million USD | -10497.732% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -209.076% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1637.871% |
| PureTech Health plc | -146.19 Million USD | -253.71% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -2423.649% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -119.493% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2027.491% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -88.727% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1664.617% |
| Acelyrin, Inc. | -422.06 Million USD | -22.522% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -4010162.94% |
| Summit Therapeutics Inc. | -89.73 Million USD | -476.269% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1295.211% |
| Senti Biosciences, Inc. | -92.72 Million USD | -457.681% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -350.56% |
| Elevation Oncology, Inc. | -45.44 Million USD | -1037.905% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1409.093% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -13018.08% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -16254.238% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1466.037% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5983.061% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -660.517% |
| Seer, Inc. | -103.46 Million USD | -399.812% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -686.388% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -618.893% |
| ESSA Pharma Inc. | -32.13 Million USD | -1509.259% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1216.657% |
| GT Biopharma, Inc. | -13.57 Million USD | -3709.082% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -135.89% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -1017.954% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 695.679% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -811.082% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -904.001% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -5103.657% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | -2.539% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -7396.68% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -920.103% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -99.154% |
| Aptose Biosciences Inc. | -52.35 Million USD | -887.702% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -3485.945% |
| Soligenix, Inc. | -7.69 Million USD | -6617.654% |
| Century Therapeutics, Inc. | -146.54 Million USD | -252.873% |
| Kura Oncology, Inc. | -165.8 Million USD | -211.887% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -453.319% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -6116.144% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -20737.882% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -7875.339% |
| Autolus Therapeutics plc | -195.02 Million USD | -165.152% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -510.843% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -602.019% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -2346.752% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -127.771% |
| GRI Bio, Inc. | -11.38 Million USD | -4441.328% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -11351.586% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -294.168% |
| IGM Biosciences, Inc. | -263.46 Million USD | -96.28% |
| INmune Bio, Inc. | -29.74 Million USD | -1638.748% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -367.496% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1258.153% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3136.181% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -3178.972% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -746.38% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -380.944% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -87.359% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -154.49% |
| Verastem, Inc. | -92.08 Million USD | -461.575% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -997.106% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -180.823% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -336.831% |
| Histogen Inc. | -10.64 Million USD | -4758.79% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -3242.311% |
| Surrozen, Inc. | -45.78 Million USD | -1029.578% |
| Organovo Holdings, Inc. | -15.08 Million USD | -3327.82% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -10059.077% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -772.315% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -908.151% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1945.574% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -6674.946% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -201.91% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -967.374% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -561.238% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -3297.468% |
| Apollomics, Inc. | -54.83 Million USD | -843.066% |
| Amarin Corporation plc | -67.58 Million USD | -665.108% |
| Mesoblast Limited | -58.79 Million USD | -779.547% |
| Turnstone Biologics Corp. | -59.03 Million USD | -776.001% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -212.403% |
| Synaptogenix, Inc. | -8.31 Million USD | -6119.991% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -3445.324% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -463.982% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -10692.542% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -5755.591% |
| Exelixis, Inc. | 170.88 Million USD | 402.613% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1251.526% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -233.491% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4279.76% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -6330.329% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1624.139% |
| Gritstone bio, Inc. | -154.63 Million USD | -234.416% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -650.964% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -2920.028% |
| Avid Bioservices, Inc. | -18.67 Million USD | -2668.61% |
| Insmed Incorporated | -709.62 Million USD | 27.128% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -3195.908% |
| MediWound Ltd. | -15.29 Million USD | -3282.086% |
| OmniAb, Inc. | -69.41 Million USD | -644.927% |
| Alector, Inc. | -151.74 Million USD | -240.794% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -378.891% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -891.641% |
| Zai Lab Limited | -366.57 Million USD | -41.069% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -63.244% |
| Aura Biosciences, Inc. | -84.99 Million USD | -508.442% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -110.641% |
| Immunic, Inc. | -99.22 Million USD | -421.17% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -261.224% |
| Veracyte, Inc. | -85.79 Million USD | -502.74% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -83.497% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3539.134% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -7407.622% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -2651.724% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 189.378% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1931.67% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1432.717% |
| TG Therapeutics, Inc. | 20.63 Million USD | 2606.281% |
| Galecto, Inc. | -39.9 Million USD | -1195.88% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -1129.075% |
| Fortrea Holdings Inc. | 63.1 Million USD | 919.526% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -268.202% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1690.709% |
| XBiotech Inc. | -37.51 Million USD | -1278.622% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -650.964% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -670.442% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -379.233% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1914.339% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -870.354% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 9.151% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -558.82% |
| Vaxxinity, Inc. | -58.28 Million USD | -787.228% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -398.627% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -2223.812% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -498.409% |
| NexImmune, Inc. | -29.19 Million USD | -1671.419% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -9101.225% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -3446.448% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 112.778% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1931.191% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4314.225% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -306.983% |
| Ainos, Inc. | -13.2 Million USD | -3815.686% |
| Pluri Inc. | -22.15 Million USD | -2233.789% |
| Prothena Corporation plc | -191.03 Million USD | -170.693% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -274.622% |
| Celularity Inc. | -192.28 Million USD | -168.932% |
| Rallybio Corporation | -78.93 Million USD | -555.147% |
| Cue Biopharma, Inc. | -52.14 Million USD | -891.622% |
| MeiraGTx Holdings plc | -137.06 Million USD | -277.293% |
| Omeros Corporation | -164.53 Million USD | -214.302% |
| Humacyte, Inc. | -100.04 Million USD | -416.878% |
| Immunocore Holdings plc | -59.64 Million USD | -766.94% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -2686.362% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -2012.164% |
| Blueprint Medicines Corporation | -486.27 Million USD | -6.343% |
| CalciMedica, Inc. | -21.87 Million USD | -2263.982% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -592.635% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -293.293% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -201.889% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -58.189% |
| Pulmatrix, Inc. | -14.74 Million USD | -3408.284% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1346.695% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -481.911% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | -0.355% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -665.527% |
| Cytokinetics, Incorporated | -496.2 Million USD | -4.215% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1402.429% |
| Nutriband Inc. | -4.87 Million USD | -10514.303% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -1085.704% |
| Vor Biopharma Inc. | -126.03 Million USD | -310.296% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 112.19% |
| Evogene Ltd. | -26.39 Million USD | -1859.46% |
| ProKidney Corp. | -151.52 Million USD | -241.284% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -701.303% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -6622.63% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 14.859% |
| CorMedix Inc. | -48.95 Million USD | -956.259% |
| BioLineRx Ltd. | -49.69 Million USD | -940.611% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -352.928% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1258.271% |
| Atai Life Sciences N.V. | -125.47 Million USD | -312.144% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -533.422% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -535.214% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -107.689% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1582.241% |
| MediciNova, Inc. | -9.9 Million USD | -5123.305% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -309.202% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -7040.13% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1833.673% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -123.065% |
| Biomea Fusion, Inc. | -126.13 Million USD | -309.974% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -48.002% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1719.823% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -170.618% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -124.88% |
| Absci Corporation | -115.51 Million USD | -347.666% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1774.51% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -358.168% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -113.543% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1952.393% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -148.623% |
| Allakos Inc. | -196.05 Million USD | -163.762% |
| Imunon, Inc. | -21.03 Million USD | -2358.918% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -367.289% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 582.02% |
| BioAtla, Inc. | -129.68 Million USD | -298.745% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4279.76% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -3164.035% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -57.785% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -1138.376% |
| XOMA Corporation | -41.84 Million USD | -1135.713% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -391.387% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -325.632% |
| aTyr Pharma, Inc. | -54.91 Million USD | -841.607% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -491.489% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -199.139% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -103.231% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -2309.024% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -6196.559% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2977.002% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5847680.682% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 253.187% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -7814.283% |
| UroGen Pharma Ltd. | -65.53 Million USD | -689.064% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -479.226% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -7019.925% |
| Orgenesis Inc. | -53.63 Million USD | -864.13% |
| Entera Bio Ltd. | -8.89 Million USD | -5716.23% |
| GH Research PLC | -41.22 Million USD | -1154.478% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1911.518% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -522.64% |
| Xencor, Inc. | -138.63 Million USD | -272.998% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -9932.257% |
| Replimune Group, Inc. | -234.77 Million USD | -120.264% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -2306.208% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -3606.429% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -7814.283% |
| Portage Biotech Inc. | -18.25 Million USD | -2733.074% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -7040.13% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -392.679% |
| OncoCyte Corporation | -25.13 Million USD | -1957.292% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4474.326% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4413.557% |
| Purple Biotech Ltd. | 22.27 Million USD | 2421.948% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -6783.932% |
| scPharmaceuticals Inc. | -55.39 Million USD | -833.499% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -2636.424% |
| HilleVax, Inc. | -133.34 Million USD | -287.807% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -4191.817% |
| Tharimmune, Inc. | -9.45 Million USD | -5369.159% |
| Genprex, Inc. | -31.07 Million USD | -1564.076% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -174.781% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1548.089% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -67497.516% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -9393.826% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3283264.223% |
| Savara Inc. | -60 Million USD | -761.768% |
| Curis, Inc. | -48.33 Million USD | -969.935% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1576.793% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -9811.697% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -7006.239% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1797.692% |
| BeiGene, Ltd. | -1.2 Billion USD | 57.183% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -2493.476% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | -6.145% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -452.173% |
| Erasca, Inc. | -141.52 Million USD | -265.392% |
| bluebird bio, Inc. | -244.26 Million USD | -111.708% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -11323.105% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 365.953% |
| DBV Technologies S.A. | -76.43 Million USD | -576.577% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -11323.105% |
| Moderna, Inc. | -4.23 Billion USD | 87.801% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1113.643% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -8030.833% |
| Molecular Templates, Inc. | -10.46 Million USD | -4840.961% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -669.102% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -37.261% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -260.838% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -894.597% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -234.615% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -148.461% |
| MacroGenics, Inc. | -168.24 Million USD | -207.364% |
| RenovoRx, Inc. | -11.39 Million USD | -4437.741% |
| Adicet Bio, Inc. | -152.03 Million USD | -240.126% |
| Prime Medicine, Inc. | -191.29 Million USD | -170.331% |
| Aditxt, Inc. | -26.06 Million USD | -1884.163% |
| Adagene Inc. | -23.71 Million USD | -2080.118% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6974.064% |
| Quantum-Si incorporated | -111.17 Million USD | -365.158% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1533.977% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3447.326% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 523.821% |
| SciSparc Ltd. | -5.77 Million USD | -8857.578% |
| Vericel Corporation | -6.46 Million USD | -7900.015% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5873.675% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -2136.724% |
| Generation Bio Co. | -138.56 Million USD | -273.203% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -522.812% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -498.104% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -114.483% |
| Invivyd, Inc. | -207.78 Million USD | -148.876% |
| Relay Therapeutics, Inc. | -373 Million USD | -38.638% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -5413.896% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 2507.341% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4926.937% |
| 2seventy bio, Inc. | -216.7 Million USD | -138.631% |
| ADMA Biologics, Inc. | 21.63 Million USD | 2490.537% |
| Clene Inc. | -40.54 Million USD | -1175.582% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -2047.703% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -843.72% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1833.673% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -47.724% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1307.821% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 3316.527% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -398.661% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1420.855% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -203.692% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 24.431% |
| Evaxion Biotech A/S | -22.19 Million USD | -2229.689% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -527.711% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -131.764% |
| Trevena, Inc. | -35.28 Million USD | -1365.43% |
| Surrozen, Inc. | -45.78 Million USD | -1029.578% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -546.846% |
| Cingulate Inc. | -22.75 Million USD | -2172.141% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 7002.309% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -1057.725% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -6180.358% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -404.223% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -604.726% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -733.072% |
| Clearmind Medicine Inc. | -8.74 Million USD | -5815.802% |
| Kronos Bio, Inc. | -121.83 Million USD | -324.461% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -578.672% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -17531.219% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -412.879% |
| Statera Biopharma, Inc. | -98.34 Million USD | -425.83% |
| ImmunityBio, Inc. | -362.25 Million USD | -42.753% |
| Korro Bio, Inc. | -84.53 Million USD | -511.731% |
| Kineta, Inc. | -15.72 Million USD | -3188.946% |
| BioVie Inc. | -32.17 Million USD | -1506.985% |
| Codexis, Inc. | -68.06 Million USD | -659.701% |
| Celularity Inc. | -192.28 Million USD | -168.932% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -132.301% |
| Celcuity Inc. | -66.23 Million USD | -680.792% |
| Virax Biolabs Group Limited | -6.49 Million USD | -7860.027% |
| Cibus, Inc. | -318.88 Million USD | -62.166% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -1102.607% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1427.955% |
| IN8bio, Inc. | -30.33 Million USD | -1604.588% |
| Kodiak Sciences Inc. | -277.32 Million USD | -86.47% |
| Annexon, Inc. | -143.72 Million USD | -259.804% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -317.737% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -699.927% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -2105.771% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -46.191% |
| Eyenovia, Inc. | -25.4 Million USD | -1935.393% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1684.317% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -9197.393% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -553.483% |
| Arcellx, Inc. | -89.88 Million USD | -475.346% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -1038.732% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -276.891% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1562.287% |
| Moolec Science SA | -6.65 Million USD | -7671.809% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -745.826% |
| Geron Corporation | -193.94 Million USD | -166.634% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -1095.573% |
| Royalty Pharma plc | 1.49 Billion USD | 134.656% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -215.007% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -5443.83% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -2261.859% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -202.486% |
| Humacyte, Inc. | -100.04 Million USD | -416.878% |
| Structure Therapeutics Inc. | -102.77 Million USD | -403.158% |
| 89bio, Inc. | -151.2 Million USD | -242.002% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -545.336% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -3456.541% |
| Genelux Corporation | -24.16 Million USD | -2039.959% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1424.396% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -201.089% |
| Notable Labs, Ltd. | -14.65 Million USD | -3428.15% |
| Liquidia Corporation | -73.38 Million USD | -604.678% |
| Mustang Bio, Inc. | -50.72 Million USD | -919.44% |
| Immunovant, Inc. | -282.7 Million USD | -82.916% |
| Quantum-Si incorporated | -111.17 Million USD | -365.158% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -562.101% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -2331.565% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -406.922% |
| Acasti Pharma Inc. | -11.31 Million USD | -4471.437% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -2156.091% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3136.181% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -141.584% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -13994.054% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -3155.2% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1673.574% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -1149.567% |
| PepGen Inc. | -84.76 Million USD | -510.057% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1645.203% |
| United Therapeutics Corporation | 1.18 Billion USD | 143.643% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2158.466% |
| Solid Biosciences Inc. | -104.31 Million USD | -395.73% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1476.198% |
| Immuneering Corporation | -58.41 Million USD | -785.286% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -10059.077% |
| Silo Pharma, Inc. | -3.85 Million USD | -13312.233% |
| Belite Bio, Inc | -31.66 Million USD | -1532.945% |
| XOMA Corporation | -41.84 Million USD | -1135.713% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -665.878% |
| Bionomics Limited | -17.89 Billion USD | 97.11% |
| Apogee Therapeutics, Inc. | -93 Million USD | -456.026% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1549.33% |
| uniQure N.V. | -282.87 Million USD | -82.812% |
| Cassava Sciences, Inc. | -105.95 Million USD | -388.048% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -6974.064% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -299.309% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1491.827% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -6123.809% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1659.214% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -9197.393% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3539.134% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -5717.539% |
| Altimmune, Inc. | -95.92 Million USD | -439.066% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -603.623% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1549.33% |
| Compugen Ltd. | -12.99 Million USD | -3880.303% |
| Peak Bio, Inc. | -1356.23 USD | -38129199.603% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -942.499% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2199.337% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -113.419% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1638.456% |
| Zura Bio Limited | -62.63 Million USD | -725.571% |
| PolyPid Ltd. | -22.86 Million USD | -2161.429% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -3077.2% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1638.456% |
| Instil Bio, Inc. | -159.16 Million USD | -224.888% |
| argenx SE | -425.04 Million USD | -21.662% |
| Immunome, Inc. | -109.53 Million USD | -372.127% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -926.788% |
| Verona Pharma plc | -67.83 Million USD | -662.368% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1884.348% |
| Shattuck Labs, Inc. | -91.95 Million USD | -462.351% |
| CervoMed Inc. | -7.81 Million USD | -6518.814% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -607.319% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -3781.998% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -973.444% |
| Moolec Science SA | -6.65 Million USD | -7671.809% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -3043.891% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -282.411% |
| AnaptysBio, Inc. | -164.41 Million USD | -214.529% |
| Design Therapeutics, Inc. | -78.19 Million USD | -561.365% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -494.112% |
| NeurAxis, Inc. | -6.66 Million USD | -7659.343% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1176.874% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1312.359% |
| Achilles Therapeutics plc | -75.25 Million USD | -587.158% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1884.348% |
| 180 Life Sciences Corp. | -13.47 Million USD | -3736.921% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 10128.895% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -17531.219% |
| Nutriband Inc. | -4.87 Million USD | -10514.303% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -366.8% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -832.607% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -917.234% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -682.343% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -855.453% |
| Palisade Bio, Inc. | -13.07 Million USD | -3856.549% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -1038.807% |
| Beam Therapeutics Inc. | -176.48 Million USD | -193.011% |
| Neurogene Inc. | -55.58 Million USD | -830.358% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -373.754% |
| AEON Biopharma, Inc. | -48.42 Million USD | -967.792% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -434.713% |
| Sesen Bio, Inc. | -25.9 Million USD | -1895.913% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -519.092% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -4008.408% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -12.281% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -613.871% |
| Athira Pharma, Inc. | -125.46 Million USD | -312.16% |
| Vaccinex, Inc. | -22.88 Million USD | -2159.65% |
| HCW Biologics Inc. | -25.71 Million USD | -1910.801% |
| XOMA Corporation | -41.84 Million USD | -1135.713% |
| Nektar Therapeutics | -137.42 Million USD | -276.293% |
| Arvinas, Inc. | -401.5 Million USD | -28.797% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5847680.682% |
| Merus N.V. | -156.54 Million USD | -230.33% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -415.775% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1393.706% |
| Rezolute, Inc. | -70.42 Million USD | -634.307% |
| Clene Inc. | -40.54 Million USD | -1175.582% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -3057.321% |
| BeyondSpring Inc. | -23.11 Million USD | -2137.263% |
| Synlogic, Inc. | -55.16 Million USD | -837.476% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -2784.271% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4677.541% |
| Peak Bio, Inc. | -1356.23 USD | -38129199.603% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1176.747% |
| Krystal Biotech, Inc. | -109.72 Million USD | -371.28% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -299.198% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -50.758% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -10796.041% |
| MannKind Corporation | 8.67 Million USD | 6058.988% |
| Ikena Oncology, Inc. | -75.41 Million USD | -585.682% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -5260.433% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -669.182% |
| Gossamer Bio, Inc. | -183.75 Million USD | -181.413% |
| CohBar, Inc. | -12.38 Million USD | -4074.27% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -919.48% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1774.51% |
| Legend Biotech Corporation | -439.48 Million USD | -17.665% |
| Mural Oncology plc | -194.63 Million USD | -165.683% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -670.179% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -3102.926% |
| Disc Medicine, Inc. | -91.12 Million USD | -467.485% |
| Champions Oncology, Inc. | -7.35 Million USD | -6929.921% |
| REGENXBIO Inc. | -268.12 Million USD | -92.863% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4724.706% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -827.471% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1227.291% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -352.199% |
| Vaxart, Inc. | -83.34 Million USD | -520.443% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -5969.49% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -1108.394% |
| Cellectis S.A. | -106.62 Million USD | -384.986% |
| Longeveron Inc. | -21.02 Million USD | -2359.085% |
| Repare Therapeutics Inc. | -116.22 Million USD | -344.935% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -93.082% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -583.616% |
| Revolution Medicines, Inc. | -487.18 Million USD | -6.145% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -7673.918% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -1076.505% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -593.285% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -642.617% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -4596.404% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 112.005% |
| Denali Therapeutics Inc. | -196.69 Million USD | -162.9% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5873.675% |
| Veru Inc. | -93.78 Million USD | -451.406% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -2116.645% |
| Cingulate Inc. | -22.75 Million USD | -2172.141% |
| Passage Bio, Inc. | -108.38 Million USD | -377.097% |
| Context Therapeutics Inc. | -25.07 Million USD | -1962.493% |
| Exicure, Inc. | -14.99 Million USD | -3348.393% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -150.952% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -1173.76% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -5221.852% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -180.5% |
| Nuvalent, Inc. | -149.49 Million USD | -245.919% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -6193.683% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -482.796% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -2389.27% |
| OmniAb, Inc. | -69.41 Million USD | -644.927% |
| Anew Medical, Inc. | -1.3 Million USD | -39652.852% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -3949.182% |
| Lipocine Inc. | -17.93 Million USD | -2783.957% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -654.778% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -579.064% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1258.153% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1208.273% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -2210.226% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 10.818% |
| Ocugen, Inc. | -65.53 Million USD | -689.124% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -450.914% |
| Q32 Bio Inc. | -92.1 Million USD | -461.466% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -2312.057% |
| Alumis Inc. Common Stock | -158.17 Million USD | -226.932% |
| Equillium, Inc. | -14.52 Million USD | -3460.949% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -728.64% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -6443.062% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2641.15% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -1001.406% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -376.759% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -4220.137% |
| Dominari Holdings Inc. | -21.79 Million USD | -2272.55% |
| Edesa Biotech, Inc. | -9.22 Million USD | -5507.01% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1927.766% |
| Bio-Techne Corporation | 206.68 Million USD | 350.196% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -32.091% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 369.292% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -290.938% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1246.985% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -242.235% |
| Nkarta, Inc. | -131.65 Million USD | -292.8% |
| BioCardia, Inc. | -11.64 Million USD | -4341.094% |
| Iterum Therapeutics plc | -47.46 Million USD | -989.41% |